← SynDRA
ZOPOLRESTAT
SynDRA canonical compound SYN0000451 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AKR1B1 | AKR1B10 |
All known targets
Mechanisms of action (all sources)
- AKR1B1 INHIBITOR
- AKR1B1 MODULATOR
Drug classes
- Enzyme Inhibitors
- Hypoglycemic Agents
Cross-references
Synonyms
- Alond
- CP-73,850
- CP-73850
- Xedia
- CP 73850
- Zopolrestatum [INN-Latin]
- UNII-1PV3S9WP3D
- C19H12F3N3O3S
- 1PV3S9WP3D
- CHEMBL10372
- 3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid
- 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid
- 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid
- 3,4-Dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazineacetic acid
- Zopolrestatum
- RefChem:905383
- DTXCID3071856
- ZST
- Zopolrestat [USAN:INN:BAN]
- 4kyh
- MFCD00865476
- Alond (TN)
- ZOPOLRESTAT [MI]
- ZOPOLRESTAT [INN]
- Zopolrestat (USAN/INN)
- ZOPOLRESTAT [USAN]
- SCHEMBL49012
- ZOPOLRESTAT [WHO-DD]
- MLS006010619
- GTPL7419
- orb1304115
- SCHEMBL29353641
- BDBM16452
- Zopolrestat, >=98% (HPLC)
- AKOS040754579
- EBC-499076
- DA-72363
- HY-19687
Look up ZOPOLRESTAT in the interactive SynDRA portal →